← Leaderboards
Jeffrey A Meyerhardt
Dana-Farber Cancer Inst
$15,207,814
Attributed
$20,410,965
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,410,965 · 10
By mechanism
R01$6,517,950 · 2
P30$5,739,432 · 4
U01$3,672,781 · 1
U54$1,903,900 · 1
P50$1,895,252 · 1
K07$681,650 · 1
Top collaborators
- Bette J Caan10 shared
- Justin C Brown5 shared
- Kathryn H. Schmitz5 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Frank S Hodi$11,927,265
- Shuji Ogino$10,631,973
- Jean Zhao$18,430,855
- Katrin Jennifer Svensson$3,827,463
Others in their field
Top investigators on “Colon Carcinoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$175,335,637
- Norman Wolmark · Nsabp Foundation, Inc.$48,722,384
- Robert J Coffey · Vanderbilt University$27,051,989
- Sanford D Markowitz · Case Western Reserve University$24,708,814
- Judith A James · Oklahoma Medical Research Foundation$20,921,391
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$20,805,164
Research focus
Colon CarcinomaMalignant NeoplasmsResponseCancer PatientParticipantClinical ResearchColorectal CancerDana-Farber Cancer InstitutePharmaceutical PreparationsRandomizedToxic EffectDoseChemotherapyDiagnosisPathway InteractionsClinical TrialsCancer CenterExerciseEnsureBody CompositionReportingBody Mass IndexCharacteristicsObesity
Grant awards (38)
Clinical Protocol and Data Management$817,523
P30 · FY2025 · CA · contact PI
Protocol Review and Monitoring System$423,736
P30 · FY2025 · CA · contact PI
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer$373,541
U01 · FY2025 · CA
Clinical Protocol and Data Management$952,105
P30 · FY2024 · CA · contact PI
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer$737,025
U01 · FY2024 · CA
Protocol Review and Monitoring System$509,824
P30 · FY2024 · CA · contact PI
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer$302,223
U01 · FY2024 · CA
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer$1,075,931
U01 · FY2023 · CA
Clinical Protocol and Data Management$988,546
P30 · FY2023 · CA · contact PI
Protocol Review and Monitoring System$529,575
P30 · FY2023 · CA · contact PI
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer$1,184,061
U01 · FY2022 · CA
Clinical Protocol and Data Management$988,548
P30 · FY2022 · CA · contact PI
Protocol Review and Monitoring System$529,575
P30 · FY2022 · CA · contact PI
Resistance Training to Reduce Chemotoxicity in Colon Cancer$788,917
R01 · FY2021 · CA
Resistance Training to Reduce Chemotoxicity in Colon Cancer$790,915
R01 · FY2020 · CA
Resistance Training to Reduce Chemotoxicity in Colon Cancer$818,198
R01 · FY2019 · CA
Resistance Training to Reduce Chemotoxicity in Colon Cancer$863,821
R01 · FY2018 · CA
Resistance Training to Reduce Chemotoxicity in Colon Cancer$870,094
R01 · FY2017 · CA
Exercise and Metformin to Impact Hyperinsulinemia in Colorectal Cancer Survivors$387,059
U54 · FY2015 · CA · contact PI
The Influence of Diet and Lifestyle on Patients with Advanced Colorectal Cancer$417,796
R01 · FY2014 · CA · contact PI
Exercise and Metformin to Impact Hyperinsulinemia in Colorectal Cancer Survivors$401,075
U54 · FY2014 · CA · contact PI
The Influence of Diet and Lifestyle on Patients with Advanced Colorectal Cancer$463,060
R01 · FY2013 · CA · contact PI
Exercise and Metformin to Impact Hyperinsulinemia in Colorectal Cancer Survivors$358,430
U54 · FY2013 · CA · contact PI
The Influence of Diet and Lifestyle on Patients with Advanced Colorectal Cancer$624,828
R01 · FY2012 · CA · contact PI
Exercise and Metformin to Impact Hyperinsulinemia in Colorectal Cancer Survivors$368,198
U54 · FY2012 · CA · contact PI
The Influence of Diet and Lifestyle on Patients with Advanced Colorectal Cancer$506,666
R01 · FY2011 · CA · contact PI
Exercise and Metformin to Impact Hyperinsulinemia in Colorectal Cancer Survivors$389,138
U54 · FY2011 · CA · contact PI
The Role of PI3-Kinase Signaling Pathway in Defining Sensitivity and Resistance$364,242
P50 · FY2011 · CA · contact PI
The Role of PI3-Kinase Signaling Pathway in Defining Sensitivity and Resistance$401,646
P50 · FY2010 · CA · contact PI
The Influence of Diet and Lifestyle on Patients with Advanced Colorectal Cancer$373,655
R01 · FY2010 · CA · contact PI
The Role of PI3-Kinase Signaling Pathway in Defining Sensitivity and Resistance$397,993
P50 · FY2009 · CA · contact PI
The Role of PI3-Kinase Signaling Pathway in Defining Sensitivity and Resistance$383,423
P50 · FY2008 · CA · contact PI
The Role of PI3-Kinase Signaling Pathway in Defining Sensitivity and Resistance$347,948
P50 · FY2007 · CA · contact PI
Predictors of Outcome in Colorectal Cancer$136,626
K07 · FY2007 · CA · contact PI
Predictors of Outcome in Colorectal Cancer$136,626
K07 · FY2006 · CA · contact PI
Predictors of Outcome in Colorectal Cancer$136,626
K07 · FY2005 · CA
Predictors of Outcome in Colorectal Cancer$136,066
K07 · FY2004 · CA
Predictors of Outcome in Colorectal Cancer$135,706
K07 · FY2003 · CA